Long Term Treatment by a Long Acting Somatostatin Analogue (Sms 201–995) in a 4 Months Boy Presenting With Primary Permanent Hyperinsulinism
Pediatric Research - United States
doi 10.1203/00006450-198801000-00204
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 1988
Authors
Publisher
Springer Science and Business Media LLC